Attached files
file | filename |
---|---|
EX-10.1 - EXHIBIT 10.1 - SANUWAVE Health, Inc. | c98704exv10w1.htm |
EX-10.2 - EXHIBIT 10.2 - SANUWAVE Health, Inc. | c98704exv10w2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 31, 2010
SANUWAVE HEALTH, INC.
(Exact name of registrant as specified in its charter)
Nevada | 000-52985 | 20-1176000 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
11680 Great Oaks Way, Suite 350, Alpharetta, Georgia |
30022 |
|
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (678) 581-6843
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 | Entry into a Material Definitive Agreement. |
On March 31, 2010, SANUWAVE Health, Inc., a Nevada corporation (the Company), issued a
promissory note, in the principal amount of $300,000, to David N. Nemelka (the Nemelka Note) and
issued a promissory note, in the principal amount of $300,000, to Kevin and Margaret Richardson
(the Richardson Note and together with the Nemelka Note, the Notes). Kevin Richardson is a
member of the Companys board of directors and David N. Nemelka is one of the Companys
shareholders. The Notes accrue interest at 5% per annum. The Nemelka Note and Richardson Note,
together with all accrued and unpaid interest, are due and payable on June 30, 2010. In the event
that the Notes are not paid in full within three business days of their maturity date, then, from
and after such maturity date and until payment in full, interest will accrue on the outstanding
principal balance of the Notes at the rate of 10% per annum. Pursuant to the terms of the Notes,
the Company agreed to pay all costs and expenses of collection on the Notes, including 15% of the
amount of principal and interest involved as attorneys fees in connection with such collection.
The Notes are unsecured.
Item 2.03 | Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. |
See disclosure under Item 1.01 above.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | Description | |
10.1
|
Promissory Note, dated March 31, 2010, issued by SANUWAVE Health, Inc. to David N. Nemelka | |
10.2
|
Promissory Note, dated March 31, 2010, issued by SANUWAVE Health, Inc. to Kevin and Margaret Richardson |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SANUWAVE HEALTH, INC. |
||||
By: | /s/ Christopher M. Cashman | |||
Name: | Christopher M. Cashman | |||
Title: | President and Chief Executive Officer | |||
Dated: April 1, 2010
3